PM · 10-Q · 2026Q3 · Full report

Nicotine Product Regulation

Philip Morris International Inc. · 2026-10-23 · Importance 40 · Surprise 42 · In source text

On May 8, 2026, the FDA issued final guidance stating it does not intend to prioritize enforcement against certain unauthorized ENDS and nicotine pouch products that have demonstrated meaningful progress toward authorization. PMI says it may commercialize products without a marketing granted order where it believes enforcement would be inconsistent with the guidance, FDA practices, or the Family Smoking Prevention and Tobacco Control Act. The filing notes that such commercialization and regulatory practices remain subject to PMI’s evaluation.

Key facts

• On April 17, 2026, the FDA renewed the IQOS 2.4 and IQOS 3.0 exposure modification orders, with an expiration date in April 2031. source
• The European Commission launched a stakeholder consultation on revising the Tobacco Products Directive in May 2026 and is expected to issue a potential legislative proposal by the end of 2026. source
• PMI faces tobacco- and nicotine-product litigation in some jurisdictions, with damages claimed in some cases ranging into the billions of U.S. dollars. source
• On May 8, 2026, the FDA issued final guidance that it does not intend to prioritize enforcement against certain unauthorized ENDS and nicotine pouch products that demonstrated meaningful progress toward authorization. source
• The EU's characterizing-flavor ban for heated-tobacco products was required to apply from October 23, 2023 and affects a significant proportion of PMI's smoke-free products sold in the EU. source
• PMI received Taiwan authorization to commercialize IQOS, effective October 11, 2025. source
• In February 2025, Greece authorized a substantially similar claim and disclaimer for IQOS ILUMA devices with seven TEREA variants: Amber, Bronze, Russet, Sienna, Silver, Teak and Yellow. source
• PMI submitted bundled IQOS ILUMA premarket and modified-risk applications on October 20, 2023; the FDA formally accepted them in March 2024, and review may involve further information requests or inspections. source

Impact estimates